Hence then, the article about janssen announces positive topline results for jnj 2113 a novel first and only oral il 23 receptor antagonist peptide in development for moderate to severe plaque psoriasis was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Janssen Announces Positive Topline Results for JNJ-2113--a Novel, First and Only Oral IL-23 Receptor Antagonist Peptide in Development for Moderate-to-Severe Plaque Psoriasis )
Also on site :
- Heavy gunfire erupts near presidential palace in Caracas – reports
- Wildfire south of Lafayette prompts evacuations, closure of US Highway 287
- Castle Peak avalanche in Nevada County triggers multi-agency search effort